We are live on ! Find out more
PSC

Piper Sandler & Co Portfolio holdings

AUM $102M
1-Year Est. Return 0.13%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+0.13%
3 Year Est. Return
-0.09%
5 Year Est. Return
-7.67%
10 Year Est. Return
–
AUM
$39.4M
AUM Growth
-$54.1M
Cap. Flow
-$41.6M
Cap. Flow %
-105.57%
Top 10 Hldgs %
95.65%
Holding
123
New
16
Increased
1
Reduced
3
Closed
94

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$714K
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$462K
3
BHC icon
Bausch Health
BHC
+$222K
4
THC icon
Tenet Healthcare
THC
+$194K
5
BLUE
bluebird bio
BLUE
+$174K

Top Sells

Rank Stock Value
1
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$1.71M
2
TZA icon
Direxion Daily Small Cap Bear 3x ETF
TZA
+$1.19M
3
OFIX icon
Orthofix Medical
OFIX
+$996K
4
ESRX
Express Scripts Holding Company
ESRX
+$648K
5
EW icon
Edwards Lifesciences
EW
+$640K

Sector Composition

Rank Sector Weight
1 Healthcare 17.09%
2 Consumer Discretionary 0.45%
3 Communication Services 0%
4 Consumer Staples 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$10.2M 25.87%
50,000
+10,000
+25% +$2.05M
VTVT icon
2
vTv Therapeutics
VTVT
$121M
$4.67M 11.86%
17,150
-2,231
-12% -$626K
XLE icon
3
PUT
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$4.22M 10.71%
+140,000
New +$4.61M
TEVA icon
4
Teva Pharmaceuticals
TEVA
$35.9B
$759K 1.93%
+11,559
New +$714K
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$121B
$481K 1.22%
+3,825
New +$462K
BHC icon
6
Bausch Health
BHC
$1.65B
$201K 0.51%
+1,976
New +$222K
THC icon
7
Tenet Healthcare
THC
$20.1B
$180K 0.46%
+5,929
New +$194K
LULU icon
8
lululemon athletica
LULU
$13B
$176K 0.45%
+3,353
New +$169K
BLUE
9
DELISTED
bluebird bio
BLUE
$145K 0.37%
+174
New +$174K
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$11.5B
$145K 0.37%
+1,385
New +$145K
ARCT icon
11
Arcturus Therapeutics
ARCT
$157M
$73K 0.19%
+1,663
New +$74.9K
RLYP
12
DELISTED
RELYPSA INC COM
RLYP
$48K 0.12%
+1,702
New +$36.6K
LDRH
13
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$30K 0.08%
+1,199
New +$31.3K
GBT
14
DELISTED
Global Blood Therapeutics, Inc.
GBT
$23K 0.06%
+700
New +$30.3K
INCY icon
15
Incyte
INCY
$23.5B
$22K 0.06%
+201
New +$22.4K
OREX
16
DELISTED
Orexigen Therapeutics, Inc.
OREX
$17K 0.04%
+981
New +$23.4K
COLL icon
17
Collegium Pharmaceutical
COLL
$1.14B
$16K 0.04%
599
-201
-25% -$4.24K
SGNT
18
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$3K 0.01%
+185
New +$2.91K
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1K ﹤0.01%
65
-22,435
-100% -$278K
AACG
20
ATA Creativity
AACG
$38.3M
– –
-2,231
Closed -$6K
AAOI icon
21
Applied Optoelectronics
AAOI
$8.04B
– –
-10,000
Closed -$188K
ACLS icon
22
Axcelis
ACLS
$4.12B
– –
-6,250
Closed -$67K
ADMA icon
23
ADMA Biologics
ADMA
$1.92B
– –
-46
Closed –
ADUS icon
24
Addus HomeCare
ADUS
$2.14B
– –
-5,000
Closed -$156K
AMBA icon
25
Ambarella
AMBA
$2.99B
– –
-7,500
Closed -$433K
1
2 3 4 5

Similar funds

LIC
Laurus Investment Counsel Toronto, Canada $102M AUM 0% 1-Year Est. Return
SAM
Stembrook Asset Management Red Bank, New Jersey $102M AUM
FHM
Framtiden Holdings Management Chicago, Illinois $102M AUM
IOOF
Independent Order of Foresters Toronto, Ontario, Canada $102M AUM 16.7% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
MBAML
Marble Bar Asset Management LLP London $102M AUM
BHFP
Blom & Howell Financial Planning Modesto, California $102M AUM
IWA
Independent Wealth Advisors Cary, North Carolina $102M AUM

Piper Sandler & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Piper Sandler & Co held 123 positions worth $39.4M, down 58% from $93.5M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Piper Sandler & Co withdrew a net $41.6M in Q4 2015, closing 94 positions and reducing 3 holdings. Its most notable exit was ProShares UltraPro Short S&P 500, an estimated $1.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Piper Sandler & Co opened a new position in Teva Pharmaceuticals worth $759K.

  • Piper Sandler & Co's largest Q4 2015 buy was Teva Pharmaceuticals: 11,559 shares worth $759K.
  • Piper Sandler & Co's biggest Q4 2015 reduction was vTv Therapeutics, cutting an estimated $626K.
  • Piper Sandler & Co fully exited ProShares UltraPro Short S&P 500 in Q4 2015, selling an estimated $1.71M.
  • Piper Sandler & Co's ten largest holdings make up 96% of its $39.4M portfolio in Q4 2015.
  • Piper Sandler & Co opened 16 new positions and closed 94 in Q4 2015.
  • Piper Sandler & Co's portfolio value fell 58% quarter-over-quarter to $39.4M.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.